bioRxivNeurosciencePreprint
Kif11 overexpression rescues cognition, long-term potentiation, and spine defects in mouse and cell models of Alzheimer's disease
Esteban Lucero, Ronald K. FreundiD, Noah R. JohnsoniD, Breanna R. DoolingiD, Emily M. SullivaniD, Olga PrikhodkoiD, Md. Mahiuddin Ahmed, Mark L. Dell’AcquaiD, Heidi J. ChialiD, Huntington PotteriD
Abstract
Competitive inhibition of kinesin motor proteins by amyloid-beta (A{beta}) may contribute to alterations in the neuronal microtubule cytoskeleton that can disrupt plasticity mechanisms required for learning and memory, such as long-term potentiation (LTP), thus contributing to synaptic dysfunction and cognitive impairments associated with Alzheimers disease (AD). Here, we tested the hypothesis that overexpression of the microtubule motor protein KIF11 (Kinesin-5/Eg5) will rescue A{beta}-mediated synaptic dysfunction and cognitive impairments. We found that overexpression of Kif11 prevented spatial learning and LTP deficits in the 5xFAD mouse model of AD and rescued A{beta}-mediated decreases in postsynaptic dendritic spine density in neuronal cultures. Together, these data suggest that KIF11 function is important for preserving synaptic structures and functions that are critical for learning and memory and for protection against A{beta}-mediated loss of cognition in AD. HighlightsO_LIDeficits in cognition and long-term potentiation in the 5xFAD mouse model of Alzheimers disease are prevented by Kif11 overexpression. C_LIO_LIA{beta}-mediated dendritic spine loss is blocked by Kif11 overexpression. C_LI
- organism: mouse
- assay: electronic health records
- research focus: cell type annotation
- research focus: differential expression
- research focus: spatial domain detection
- research focus: trajectory inference
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model
Amira Latif‐Hernandez, Tao Yang, … Frank M. Longo·Alzheimer s & DementiaPeer-reviewed·May 23, 2024
- An astrocyte-derived cytokine restores synaptic plasticity in a mouse model of Alzheimer's disease
Sukanya Sarkar, Kusumika Gharami, … Subhas Chandra Biswas·bioRxiv·Mar 18, 2023
- Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice
Nicole P. Kasica, Xueyan Zhou, … Tao Ma·Journal of NeurochemistryPeer-reviewed·Dec 21, 2021
- Reducing voltage-dependent potassium channel Kv3.4 levels ameliorates synapse loss in a mouse model of Alzheimers disease
Jie Yeap, Chaitra Sathyaprakash, … Tara L. Spires‐Jones·Brain and Neuroscience AdvancesPeer-reviewed·Jan 1, 2022
- STEP inhibition prevents Aβ mediated damage in dendritic complexity and spine density in Alzheimer's disease.
Manavi Chatterjee, Jeemin Kwon, … Paul J. Lombroso·Experimental Brain ResearchPeer-reviewed·Jan 9, 2021
- Activation of the muscle-to-brain axis ameliorates neurocognitive deficits in an Alzheimer disease mouse model via enhancing neurotrophic and synaptic signaling
Hash Brown Taha, Allison Birnbaum, … Constanza J. Cortés·GeroSciencePeer-reviewed·Sep 13, 2024